Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Georgia Tech engineers have created a pill that could effectively deliver insulin and other injectable drugs, making ...

The booming uptake of anti-obesity drugs in India is further underscored by rising momentum of Eli Lilly's Mounjaro, which ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or ...

Medically reviewed by Lindsay Cook, PharmD There are various types of injectable medications for weight loss, which can be injected into the stomach or other areas. These include commonly ...

You’ve probably heard the chatter about injectable weight-loss medications and found yourself wondering if they might hold ...

UNDER EMBARGO UNTIL Tuesday, June 10, 2025, 3 a.m. EDT, CLEVELAND: A Cleveland Clinic study shows that semaglutide and tirzepatide – injectable GLP-1 drugs for obesity – produce smaller weight ...

While the renal benefits of oral semaglutide vs placebo in the SOUL trial didn't match the effects seen with the injectable formulation in the FLOW trial, the observed trends suggest improvements.

Liraglutide, an injectable form of GLP-1 medication, is somewhat more effective than oral medication options, Ali says. However, newer weight management medications have shifted the landscape of ...

Novo Nordisk has launched Wegovy in India, an anti-obesity drug aimed at managing weight and reducing cardiovascular risks. Priced between Rs 17,345 and Rs 26,050 per month, the injectable drug ...

Semaglutide: A High-Growth Market Segment Semaglutide is a GLP-1 analog that has rapidly become a blockbuster drug for type 2 diabetes and obesity, with growing use in cardiovascular risk reduction.